URL has been copied successfully!
“There’s not much more to say for CVS’ 2Q other than… wow,” one analyst commented. CVS also announced a new GLP-1 deal with Eli Lilly.

“There’s not much more to say for CVS’ 2Q other than… wow,” one analyst commented. CVS also announced a new GLP-1 deal with Eli Lilly.
JBIZNEWS LLC © 2026